Table 4 Analysis of adverse events
Group P (n = 30) | Group S0.3 (n = 29) | Group S0.5 (n = 30) | Group S0.7 (n = 30) | P value | |
|---|---|---|---|---|---|
After induction | |||||
Total number of adverse events | 2 (6.7%) | 2 (6.9%) | 3 (10.0%) | 3 (10.0%) | 1.000 |
Akinetic state | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (3.3%) | 1.000 |
Hypoxemia | 2 (6.7%) | 2 (6.9%) | 3 (10.0%) | 3 (10.0%) | 1.000 |
During the procedure | |||||
Total number of adverse events | 12 (40.0%) | 12 (41.4%) | 8 (26.7%) | 3 (10.0%)† ‡ | 0.026 |
Hypotension | 7 (23.3%) | 7 (24.1%) | 1 (3.3%)† ‡ | 1 (3.3%)† ‡ | 0.01 |
Coughing/hiccups | 5 (16.7%) | 5 (17.2%) | 6 (20.0%) | 2 (6.7%) | 0.503 |
Hypoxemia | 2 (6.7%) | 1 (3.4%) | 1 (3.3%) | 0 (0.0%) | 0.753 |
After the procedure | |||||
Total case of adverse events | 10 (33.3%) | 17 (58.6%) | 18 (60.0%) | 22 (73.3%) † | 0.016 |
Dizziness | 8 (26.7%) | 12 (41.4%) | 13 (43.3%) | 22 (73.3%)† | 0.003 |
Visual disturbance | 2 (6.7%) | 7 (24.1%) | 7 (23.3%) | 5 (16.7%) | 0.276 |
Headache | 3 (10.0%) | 1 (3.4%) | 1 (3.3%) | 3 (10.0%) | 0.628 |
Nausea/vomiting | 1 (3.3%) | 0 (0.0%) | 0 (0.0%) | 1 (3.3%) | 1.000 |
Fatigue | 0 (0.0%) | 1 (3.4%) | 0 (0.0%) | 0 (0.0%) | 0.244 |
Abdominal pain | 1 (3.3%) | 0 (0.0%) | 1 (3.3%) | 0 (0.0%) | 1.000 |